SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
-9.55%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$38.4M
AUM Growth
+$6.16M
(+19%)
Cap. Flow
+$5.59M
Cap. Flow
% of AUM
14.57%
Top 10 Holdings %
Top 10 Hldgs %
52.15%
Holding
99
New
32
Increased
12
Reduced
17
Closed
21
Top Buys
| 1 |
Actinium Pharmaceuticals
ATNM
|
$2.05M |
| 2 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
$2.04M |
| 3 |
RDGT
Ridgetech, Inc. Ordinary Shares
RDGT
|
$2.01M |
| 4 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$1.94M |
| 5 |
NMTR
9 Meters Biopharma, Inc. Common Stock
NMTR
|
$1.55M |
Top Sells
| 1 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$3.69M |
| 2 |
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
|
$2.32M |
| 3 |
Loop Industries
LOOP
|
$1.97M |
| 4 |
Biogen
BIIB
|
$1.66M |
| 5 |
Oramed Pharmaceuticals
ORMP
|
$1.17M |
Sector Composition
| 1 | Healthcare | 75.93% |
| 2 | Industrials | 3.68% |
| 3 | Technology | 3.45% |
| 4 | Consumer Discretionary | 2.95% |
| 5 | Real Estate | 2.32% |
